February 1, 2013 GLORY DAYS The performance of biotechnology stocks since the start of 2013 has been no less than stellar. The BTK and NBI are up 9% and 8% respectively, and the MTSL Model (+21%) and Traderâs Portfolios (+37%) are up sharply as well (see below).  Two of BioInvestâs recommended stocks â CNDO (+63%)[…]
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.